Elizabethkingia meningosepticum endocarditis: A rare case and special therapy

References (2)

1. Boroda K, Li L. Elizabethkingia meningosepticum in a patient with six-year bilateral perma-catheters. Case Rep Infect Dis 2014; 2014: 985306
2. Bor DH, Woolhandler S, Nardin R, Brusch J, Himmelstein DU. Infective endocarditis in the U.S., 1998-2009: a nationwide study. PLoS One 2013; 8: e60033. [CrossRef] 3. Mahmood S, Taylor KE, Overman TL, McCormick MI. Acute infective endocarditis caused by Delftia acidovorans, a rare pathogen complicating intravenous drug use. J Clin Microbiol 2012; 50: 3799-800. [CrossRef] 4. Ghafur A, Vidyalakshmi PR, Priyadarshini K, Easow JM, Raj R, Raja T. Elizabethkingia meningoseptica bacteremia in immunocompromised hosts: The first case series from India. South Asian J Cancer 2013; 2: 211-5. [CrossRef] 5. Erdem E, Abdurrahmanoğlu S, Kibar F, Yağmur M, Köksal F, Ersöz R. Posttraumatic keratitis caused by Elizabethkingia meningosepticum. Eye Contact Lens 2013; 39: 361-3. [CrossRef] 6. Jean SS, Lee WS, Chen FL, Ou TY, Hsueh PR. Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections. J Hosp Infect 2014; 86: 244-9. [CrossRef] 7. Nulens E, Bussels B, Bols A, Gordts B, van Landuyt HW. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001; 7: 391-3. [CrossRef] 8. Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004; 42: 445-8. [CrossRef] 9. Chou DW, Wu SL, Lee CT, Tai FT, Yu WL. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit. Jpn J Infect Dis 2011; 64: 520-4.